Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?

被引：5

作者：

Lambertini, Matteo ^{[1
,2
]}

Viglietti, Giulia ^{[2
]}

de Azambuja, Evandro ^{[1
]}

机构：

[1] Univ Libre Bruxelles, Inst Jules Bordet, Dept Med, Brussels, Belgium

[2] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab, Brussels, Belgium

来源：

ESMO OPEN | 2018年 / 3卷 / 03期

关键词：

OVARIAN-FUNCTION SUPPRESSION; REPORTED OUTCOMES; YOUNG-WOMEN; BC UPDATE; TAMOXIFEN; SOFT; TEXT; EXEMESTANE; CHEMOTHERAPY; PROTECTION;

D O I：

10.1136/esmoopen-2018-000350

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 28 条

[1] Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy [J].

Bellet, Meritxell ;

Gray, Kathryn P. ;

Francis, Prudence A. ;

Lang, Istvan ;

Ciruelos, Eva ;

Lluch, Ana ;

Angel Climent, Miguel ;

Catalan, Gustavo ;

Avella, Antoni ;

Bohn, Uriel ;

Gonzalez-Martin, Antonio ;

Ferrer, Roser ;

Catalan, Roberto ;

Azaro, Analia ;

Rajasekaran, Agnita ;

Morales, Josefa ;

Vazquez, Josep ;

Fleming, Gini F. ;

Price, Karen N. ;

Regan, Meredith M. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) :1584-U89

[2] Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials [J].

Bernhard, Juerg ;

Luo, Weixiu ;

Ribi, Karin ;

Colleoni, Marco ;

Burstein, Harold J. ;

Tondini, Carlo ;

Pinotti, Graziella ;

Spazzapan, Simon ;

Ruhstaller, Thomas ;

Puglisi, Fabio ;

Pavesi, Lorenzo ;

Parmar, Vani ;

Regan, Meredith M. ;

Pagani, Olivia ;

Fleming, Gini F. ;

Francis, Prudence A. ;

Price, Karen N. ;

Coates, Alan S. ;

Gelber, Richard D. ;

Goldhirsch, Aron ;

Walley, Barbara A. .

LANCET ONCOLOGY, 2015, 16 (07) :848-858

[3] Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression [J].

Burstein, Harold J. ;

Lacchetti, Christina ;

Anderson, Holly ;

Buchholz, Thomas A. ;

Davidson, Nancy E. ;

Gelmon, Karen E. ;

Giordano, Sharon H. ;

Hudis, Clifford A. ;

Solky, Alexander J. ;

Stearns, Vered ;

Winer, Eric P. ;

Griggs, Jennifer J. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) :1689-U250

[4] Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update [J].

Burstein, Harold J. ;

Temin, Sarah ;

Anderson, Holly ;

Buchholz, Thomas A. ;

Davidson, Nancy E. ;

Gelmon, Karen E. ;

Giordano, Sharon H. ;

Hudis, Clifford A. ;

Rowden, Diana ;

Solky, Alexander J. ;

Stearns, Vered ;

Winer, Eric P. ;

Griggs, Jennifer J. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (21) :2255-+

[5] De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 [J].

Curigliano, G. ;

Burstein, H. J. ;

Winer, E. P. ;

Gnant, M. ;

Dubsky, P. ;

Loibl, S. ;

Colleoni, M. ;

Regan, M. M. ;

Piccart-Gebhart, M. ;

Senn, H. -J. ;

Thurlimann, B. ;

Andre, F. ;

Baselga, J. ;

Bergh, J. ;

Bonnefoi, H. ;

Brucker, S. Y. ;

Cardoso, F. ;

Carey, L. ;

Ciruelos, E. ;

Cuzick, J. ;

Denkert, C. ;

Di Leo, A. ;

Ejlertsen, B. ;

Francis, P. ;

Galimberti, V. ;

Garber, J. ;

Gulluoglu, B. ;

Goodwin, P. ;

Harbeck, N. ;

Hayes, D. F. ;

Huang, C. -S. ;

Huober, J. ;

Khaled, H. ;

Jassem, J. ;

Jiang, Z. ;

Karlsson, P. ;

Morrow, M. ;

Orecchia, R. ;

Osborne, K. C. ;

Pagani, O. ;

Partridge, A. H. ;

Pritchard, K. ;

Ro, J. ;

Rutgers, E. J. T. ;

Sedlmayer, F. ;

Semiglazov, V. ;

Shao, Z. ;

Smith, I. ;

Toi, M. ;

Tutt, A. .

ANNALS OF ONCOLOGY, 2017, 28 (08) :1700-1712

[6]

Fleming G, 2018, CANCER RES, V78

[7] Adjuvant Ovarian Suppression in Premenopausal Breast Cancer [J].

Francis, Prudence A. ;

Regan, Meredith M. ;

Fleming, Gini F. ;

Lang, Istvan ;

Ciruelos, Eva ;

Bellet, Meritxell ;

Bonnefoi, Herve R. ;

Climent, Miguel A. ;

Da Prada, Gian Antonio ;

Burstein, Harold J. ;

Martino, Silvana ;

Davidson, Nancy E. ;

Geyer, Charles E., Jr. ;

Walley, Barbara A. ;

Coleman, Robert ;

Kerbrat, Pierre ;

Buchholz, Stefan ;

Ingle, James N. ;

Winer, Eric P. ;

Rabaglio-Poretti, Manuela ;

Maibach, Rudolf ;

Ruepp, Barbara ;

Giobbie-Hurder, Anita ;

Price, Karen N. ;

Colleoni, Marco ;

Viale, Giuseppe ;

Coates, Alan S. ;

Goldhirsch, Aron ;

Gelber, Richard D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (05) :436-446

[8] Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12 [J].

Gnant, M. ;

Mlineritsch, B. ;

Stoeger, H. ;

Luschin-Ebengreuth, G. ;

Knauer, M. ;

Moik, M. ;

Jakesz, R. ;

Seifert, M. ;

Taucher, S. ;

Bjelic-Radisic, V. ;

Balic, M. ;

Eidtmann, H. ;

Eiermann, W. ;

Steger, G. ;

Kwasny, W. ;

Dubsky, P. ;

Selim, U. ;

Fitzal, F. ;

Hochreiner, G. ;

Wette, V. ;

Sevelda, P. ;

Ploner, F. ;

Bartsch, R. ;

Fesl, C. ;

Greil, R. .

ANNALS OF ONCOLOGY, 2015, 26 (02) :313-320

[9] Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer [J].

He, Wei ;

Fang, Fang ;

Varnum, Catherine ;

Eriksson, Mikael ;

Hall, Per ;

Czene, Kamila .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (20) :2262-U59

[10]

Lambertini M, 2018, CANCER RES, V78

← 1 2 3 →